Comprehensive review highlights Ganoderma lucidum's benefits and mechanisms against diseases, including COVID-19.
Ganoderma lucidum (Lingzhi) has been utilized as a traditional medicinal fungus in East Asia for thousands of years. Modern scientific investigations have confirmed that G. lucidum contains a wealth of bioactive components, primarily polysaccharides, triterpenoids, and sterols. These constituents exhibit significant pharmacological activities, including anti-tumor, anti-inflammatory, immunomodulatory, and antiviral effects, particularly against COVID-19. This paper provides a comprehensive review of the chemical properties, extraction technologies (such as ultrasound-assisted extraction), and molecular mechanisms, focusing on the STAT3 and NF-κB signaling pathways. Furthermore, its applications in neuroprotection (e.g., Alzheimer’s disease) and metabolic regulation are discussed. Finally, artificial cultivation techniques are summarized to provide a reference for the industrial development and medical application of G. lucidum. (152 words)
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: